IIQ 3.51% 59.0¢ inoviq ltd

Ann: Quarterly Business Update and Appendix 4C, page-19

  1. 515 Posts.
    lightbulb Created with Sketch. 57
    Nice work Bd1.
    I like some of the terminology:
    "The feasibility phase was successfullycompleted in December 2018 and the program has now entered the development phase"

    "evaluate clinical performance in 2H19, followed by expectedlaunch as Laboratory Developed Tests (LDTs) in 2021."

    I like the words Successfully and Expected in reports. It shows more box ticking.

    For those like me you can read up on LDT's here:
    https://www.fda.gov/medicaldevices/productsandmedicalprocedures/invitrodiagnostics/laboratorydevelopedtests/default.htm
    "initial results showing delayed tumour growth in a malignant mesothelioma mouse model" and "will update the market on the final results ofthe cancer vaccine studies upon completion."

    Rabsie.
 
watchlist Created with Sketch. Add IIQ (ASX) to my watchlist
(20min delay)
Last
59.0¢
Change
0.020(3.51%)
Mkt cap ! $65.06M
Open High Low Value Volume
57.0¢ 60.0¢ 56.5¢ $62.32K 107.5K

Buyers (Bids)

No. Vol. Price($)
1 8800 58.0¢
 

Sellers (Offers)

Price($) Vol. No.
59.0¢ 6499 1
View Market Depth
Last trade - 16.10pm 06/08/2024 (20 minute delay) ?
IIQ (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.